post-add

Apollo Cancer Centre Kolkata Performs India’s First Robotic Surgery For Rare Crossed Fused Ectopic Kidney

Apollo Cancer Centre (ACC), Kolkata, has achieved a significant medical milestone by successfully performing India’s first robotic radical nephrectomy on a 66-year-old patient diagnosed with a rare congenital anomaly, Crossed Fused Ectopic Kidney.

Apollo Cancer Centre (ACC), Kolkata, has achieved a significant medical milestone by successfully performing India’s first robotic radical nephrectomy on a 66-year-old patient diagnosed with a rare congenital anomaly, Crossed Fused Ectopic Kidney. This condition, with fewer than ten reported cases in medical literature, involves one kidney crossing the midline and fusing with the opposite kidney, creating a complex anatomical structure.

The groundbreaking procedure was led by Dr Tarun Jindal, Senior Consultant in Uro-Oncology and Robotic Surgery, using Apollo’s state-of-the-art robotic surgical system. Crossed Fused Ectopic Kidney presents unique surgical challenges due to abnormal vascular and ureteral structures, making traditional open surgery highly risky. The robotic system’s enhanced 3D visualisation, precision, and control enabled meticulous dissection of the abnormal vasculature and fused kidney tissue.

Dr Jindal explained, “This case underscores the transformative potential of robotic surgery in addressing complex urological conditions. The precision and control offered by robotic systems enable us to navigate challenging anatomical anomalies with confidence, ensuring optimal outcomes for our patients. The patient’s successful recovery is a testament to the power of advanced surgical technology.”

The patient, admitted on 21 October 2024, underwent surgery on 23 October and was discharged on 27 October, demonstrating a swift recovery from such a complex procedure. Expressing his gratitude, the patient said, “I was apprehensive when I learned about my condition, but Dr Jindal and the team at Apollo Cancer Centre gave me hope. I’m amazed at how quickly I’ve recovered and am grateful for the care and expertise I received.”

Dr Surinder Singh Bhatia, Director – Medical Services at Apollo Cancer Centre, remarked, “Our focus has always been on leveraging the latest technology to provide world-class healthcare. This groundbreaking surgery is a shining example of how robotic systems are revolutionising treatment for even the most complex conditions. We are proud to have a team of experts like Dr Jindal, who consistently push the boundaries of medical innovation.”

Robotic-assisted surgery is emerging as a game-changer in modern medicine, particularly in Uro-Oncology. With unparalleled precision, reduced invasiveness, and shorter recovery times, it is setting new standards in patient care. By adopting and refining these technologies, Apollo Cancer Centre continues to deliver superior outcomes.

Apollo Cancer Centre has a rich legacy of over 30 years in delivering 360-degree cancer care. The network spans India, with more than 390 oncologists delivering high-end precision oncology therapy. As home to South Asia and the Middle East’s first Pencil Beam Proton Therapy Centre, Apollo remains a global destination for cancer treatment, attracting patients from 147 countries.

Also Read

Subscribe to our newsletter to get updates on our latest news